임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
16건 표시
- 1상모집 중· Diabetes Mellitus, Type 2A Trial Evaluating AMG 127 in Healthy Participants and Participants With Type 2 Diabetes Mellitus
리드: 암젠
- 1상모집 중· Metastatic Castration-resistant Prostate Cancer (mCRPC)Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer
리드: 암젠
- 1상모집 중· Small Cell Lung CancerStudy of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung Cancer (SCLC)
리드: 암젠
- 1상모집 중· Metastatic or Locally Advanced Solid Tumors With Microsatellite Instability-high (MSI-H) or Mismatched Repair Deficiency (dMMR)AMG 436 as Monotherapy and Combination Therapy in Participants With MSI-H/dMMR Solid Tumors
리드: 암젠
- 1상모집 중· Metastatic Hormone-sensitive Prostate Cancer (mHSPC)Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer
리드: 암젠
- 1상모집 중· Extensive Stage Small Cell Lung CancerA Study of Tarlatamab in Combination With AB248 in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-311)
리드: 암젠
- 1상모집 중· KRAS Altered Advanced or Metastatic Solid TumorsAMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
리드: 암젠
- 1상모집 중· Extensive Stage Small Cell Lung CancerSubcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)
리드: 암젠
- 1상모집 중· Cardiometabolic DiseaseSingle and Multiple Ascending Dose Study of AMG 513 in Participants With Obesity
리드: 암젠
- 1상모집 중· Prostate CancerStudy of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
리드: 암젠
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.